Indegy has been named the 2017 Product Leader in Industrial Cyber Security for Pharmaceutical Manufacturing by Frost & Sullivan. The award recognizes Indegy’s game-changing industrial cyber security platform for its ability to prevent operational disruptions caused by external attacks, malicious insiders or human error. It also enables pharmaceutical manufacturers to automate the integrity validation of process controllers which is an FDA requirement. Until now, this has been accomplished manually.
Sankara Narayanan, Research Analyst for Frost & Sullivan says, “While competing companies only monitor for anomalies, one of Indegy’s unique capabilities is that it can identify changes made to controllers, namely PLCs, RTUs and DCS, by employees and contractors, whether they connect to devices over the network or directly to them using a serial cable or USB drive.”
The latest version of the Indegy platform centralizes the management and configuration of threat monitoring and anomaly detection capabilities across multiple facilities. This enables global organizations to protect their industrial control systems (ICS) by maintaining unified and comprehensive visibility into all activity on Operational Technology (OT) networks spread across the country or world.
A full version of the report is available for download and more details are available on the Indegy website.